The prognostic roles of ALDH1 isoenzymes in gastric cancer

References

• JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
   PubMed Web of Science ®Google Scholar
• YangWRaufiAKlempnerSJTargeted therapy for gastric cancer: molecular pathways and ongoing investigationsBiochim Biophys Acta20141846123223724858418
   PubMed Web of Science ®Google Scholar
• ObaKPaolettiXBangYJRole of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysisEur J Cancer20134971565157723352439
   PubMed Web of Science ®Google Scholar
• DouvilleJBeaulieuRBalickiDALDH1 as a functional marker of cancer stem and progenitor cellsStem Cells Dev2009181172518573038
   PubMed Web of Science ®Google Scholar
• MaIAllanALThe role of human aldehyde dehydrogenase in normal and cancer stem cellsStem Cell Rev20117229230621103958
   PubMed Web of Science ®Google Scholar
• EhlersCLVariations in ADH and ALDH in Southwest California IndiansAlcohol Res Health2007301141717718395
   PubMedGoogle Scholar
• VasiliouVThompsonDCSmithCFujitaMChenYAldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cellsChem Biol Interact20132021–321023159885
   PubMed Web of Science ®Google Scholar
• MuzioGMaggioraMPaiuzziEOraldiMCanutoRAAldehyde dehydrogenases and cell proliferationFree Radic Biol Med201252473574622206977
   PubMed Web of Science ®Google Scholar
• PearceDJTaussigDSimpsonCCharacterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samplesStem Cells200523675276015917471
   PubMed Web of Science ®Google Scholar
• GinestierCHurMHCharafe-JauffretEALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcomeCell Stem Cell20071555556718371393
   PubMed Web of Science ®Google Scholar
• BalickiDMoving forward in human mammary stem cell biology and breast cancer prognostication using ALDH1Cell Stem Cell20071548548718938743
   PubMed Web of Science ®Google Scholar
• WakamatsuYSakamotoNOoHZExpression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancerPathol Int201262211211922243781
   PubMed Web of Science ®Google Scholar
• LeviESochackiPKhouryNPatelBBMajumdarAPCancer stem cells in Helicobacter pylori infection and aging: implications for gastric carcinogenesisWorld J Gastrointest Pathophysiol20145336637225133037
   PubMedGoogle Scholar
• LiXSXuQFuXYLuoWSALDH1A1 overexpression is associated with the progression and prognosis in gastric cancerBMC Cancer20141470525253129
   PubMed Web of Science ®Google Scholar
• Gene Expression Omnibus [database on the Internet]Bethesda, MD: National Center for Biotechnology Information, US Library of Medicine Available from: http://www.ncbi.nlm.nih.gov/geo/. Accessed.
   Google Scholar
• GyorffyBLanczkyAEklundACAn online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patientsBreast Cancer Res Treat2010123372573120020197
   PubMed Web of Science ®Google Scholar
• GyorffyBBenkeZLanczkyARecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray dataBreast Cancer Res Treat201213231025103421773767
   PubMed Web of Science ®Google Scholar
• LiuMWangGGomez-FernandezCRGuoSGREB1 functions as a growth promoter and is modulated by IL6/STAT3 in breast cancerPLoS One2012710e4641023056300
   PubMed Web of Science ®Google Scholar
• TilghmanSLTownleyIZhongQProteomic signatures of acquired letrozole resistance in breast cancer: suppressed estrogen signaling and increased cell motility and invasivenessMol Cell Proteomics20131292440245523704778
   PubMed Web of Science ®Google Scholar
• ZhouCZhongQRhodesLVProteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migrationBreast Cancer Res2012142R4522417809
   PubMed Web of Science ®Google Scholar
• MaciejczykASzelachowskaJCzapigaBElevated BUBR1 expression is associated with poor survival in early breast cancer patients: 15-year follow-up analysisJ Histochem Cytochem201361533033923392733
   PubMed Web of Science ®Google Scholar
• MaciejczykALackoAEkiertMElevated nuclear S100P expression is associated with poor survival in early breast cancer patientsHistol Histopathol201328451352423364898
   PubMed Web of Science ®Google Scholar
• MaciejczykAJagodaEWysockaTABCC2 (MRP2, cMOAT) localized in the nuclear envelope of breast carcinoma cells correlates with poor clinical outcomePathol Oncol Res201218233134221986666
   PubMed Web of Science ®Google Scholar
• AdamMANew prognostic factors in breast cancerAdv Clin Exp Med201322151523468257
   PubMed Web of Science ®Google Scholar
• IvanovaLZandbergaESilinaKPrognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cellsCancer Chemother Pharmacol201575223524625422154
   PubMed Web of Science ®Google Scholar
• WuSXueWHuangXDistinct prognostic values of ALDH1 isoenzymes in breast cancerTumour Biol20153642421242625582316
   PubMedGoogle Scholar
• OrtegaCESeidnerYDominguezIMining CK2 in cancerPLoS One2014912e11560925541719
   PubMed Web of Science ®Google Scholar
• GyorffyBSurowiakPBudcziesJLanczkyAOnline survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancerPLoS One2013812e8224124367507
   PubMed Web of Science ®Google Scholar
• GyorffyBLanczkyASzallasiZImplementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patientsEndocr Relat Cancer201219219720822277193
   PubMed Web of Science ®Google Scholar
• National Cancer Institute [database on the Internet]Rockville, MDBiorepositories and Biospecimen Research Branch, National Cancer Institute Available from: http://biospecimens.cancer.gov/relatedinitiatives/overview/caBig.asp. Accessed
   Google Scholar
• National Cancer Institute [database on the Internet]Bethesda, MDThe Cancer Genome Atlas. National Cancer Institute Available from: http://biospecimens.cancer.gov/relatedinitiatives/overview/caBig.asp/. Accessed
   Google Scholar
• GentryTFosterSWinsteadLDeibertEFiordalisiMBalberASimultaneous isolation of human BM hematopoietic, endothelial and mesenchymal progenitor cells by flow sorting based on aldehyde dehydrogenase activity: implications for cell therapyCytotherapy20079325927417464758
   PubMed Web of Science ®Google Scholar
• TraoreMZhaiLChenMCytotoxic kurubasch aldehyde from Trichilia emeticaNat Prod Res2007211131717365682
   PubMed Web of Science ®Google Scholar
• JonesKMKitsonTMKitsonKEHardmanMJTweedieJWHuman class 1 aldehyde dehydrogenase. Expression and site-directed mutagenesisAdv Exp Med Biol199537217237484376
   PubMedGoogle Scholar
• LeviBPYilmazOHDuesterGMorrisonSJAldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systemsBlood200911381670168018971422
   PubMed Web of Science ®Google Scholar
• KrupenkoNIDubardMEStricklandKCMoxleyKMOleinikNVKrupenkoSAALDH1L2 is the mitochondrial homolog of 10-formyltetrahydrofolate dehydrogenaseJ Biol Chem201028530230562306320498374
   PubMed Web of Science ®Google Scholar
• TomitaHTanakaKTanakaTHaraAAldehyde dehydrogenase 1A1 in stem cells and cancerOncotarget2016710110181103226783961
   PubMedGoogle Scholar
• LiuYLvDLDuanJJALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysisBMC Cancer20141444424938375
   PubMed Web of Science ®Google Scholar
• ZhouLJiangYYanTThe prognostic role of cancer stem cells in breast cancer: a meta-analysis of published literaturesBreast Cancer Res Treat2010122379580120571867
   PubMed Web of Science ®Google Scholar
• ChenJXiaQJiangBPrognostic value of cancer stem cell marker ALDH1 expression in colorectal cancer: a systematic review and meta-analysisPLoS One20151012e014516426682730
   PubMed Web of Science ®Google Scholar
• HuoWDuMPanXZhuXLiZPrognostic value of ALDH1 expression in lung cancer: a meta-analysisInt J Clin Exp Med2015822045205125932135
   PubMed Web of Science ®Google Scholar
• WeiDPengJJGaoHZhangTTanYHuYHALDH1 expression and the prognosis of lung cancer: a systematic review and meta-analysisHeart Lung Circ201524878078825921687
   PubMed Web of Science ®Google Scholar
• ZhouCSunBThe prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysisOral Oncol201450121144114825264224
   PubMed Web of Science ®Google Scholar
• AdamSASchnellOPoschlJALDH1A1 is a marker of astrocytic differentiation during brain development and correlates with better survival in glioblastoma patientsBrain Pathol201222678879722417385
   PubMed Web of Science ®Google Scholar
• LiuYBagliaMZhengYALDH1A1 mRNA expression in association with prognosis of triple-negative breast cancerOncotarget2015638413604136926462023
   PubMedGoogle Scholar
• VasiliouVPappaAPetersenDRRole of aldehyde dehydrogenases in endogenous and xenobiotic metabolismChem Biol Interact20001291–211911154732
   PubMed Web of Science ®Google Scholar
• VasiliouVNebertDWAnalysis and update of the human aldehyde dehydrogenase (ALDH) gene familyHum Genomics20052213814316004729
   PubMedGoogle Scholar
• BurgerPEGuptaRXiongXHigh aldehyde dehydrogenase activity: a novel functional marker of murine prostate stem/progenitor cellsStem Cells20092792220222819544409
   PubMed Web of Science ®Google Scholar
• ChuteJPMuramotoGGWhitesidesJInhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cellsProc Natl Acad Sci USA200610331117071171216857736
   PubMed Web of Science ®Google Scholar
• KatsunoYEhataSYashiroMYanagiharaKHirakawaKMiyazonoKCoordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-betaJ Pathol2012228339140422430847
   PubMed Web of Science ®Google Scholar
• MieogJSdeKEMBastiaannetEAge determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancerBMC Cancer2012124222280212
   PubMed Web of Science ®Google Scholar
• NeumeisterVAgarwalSBordeauxJCampRLRimmDLIn situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosisAm J Pathol201017652131213820228222
   PubMed Web of Science ®Google Scholar
• WangKChenXZhanYIncreased expression of ALDH1A1 protein is associated with poor prognosis in clear cell renal cell carcinomaMed Oncol201330257423585015
   PubMed Web of Science ®Google Scholar
• XuSLZengDZDongWGDistinct patterns of ALDH1A1 expression predict metastasis and poor outcome of colorectal carcinomaInt J Clin Exp Pathol2014762976298625031716
   PubMed Web of Science ®Google Scholar
• YangLRenYYuXALDH1A1 defines invasive cancer stem-like cells and predicts poor prognosis in patients with esophageal squamous cell carcinomaMod Pathol201427577578324201124
   PubMed Web of Science ®Google Scholar
• XuJMullerSNannapaneniSComparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancerEur J Cancer201248111682169122341992
   PubMed Web of Science ®Google Scholar
• KeymoosiHGheytanchiEAsgariMShariftabriziAMadjdZALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladderAsian Pac J Cancer Prev20141552013202024716927
   PubMedGoogle Scholar
• CarcasLPGastric cancer reviewJ Carcinog2014131425589897
   PubMedGoogle Scholar
• TaiWMahatoRChengKThe role of HER2 in cancer therapy and targeted drug deliveryJ Control Release2010146326427520385184
   PubMed Web of Science ®Google Scholar
• TzaharEYardenYThe ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligandsBiochim Biophys Acta199813771M25M379540810
   PubMed Web of Science ®Google Scholar
• RuschoffJHannaWBilousMHER2 testing in gastric cancer: a practical approachMod Pathol201225563765022222640
   PubMed Web of Science ®Google Scholar
• RajagopalINivedithaSRSahadevRNagappaPKRajendraSGHER 2 expression in gastric and gastro-esophageal junction (GEJ) adenocarcinomasJ Clin Diagn Res201593EC06EC1025954623
   PubMedGoogle Scholar
• ElimovaEWadhwaRShiozakiHMolecular biomarkers in gastric cancerJ Natl Compr Canc Netw2015134e19e2926052595
   PubMedGoogle Scholar
• YoshiokaTUmekitaYOhiYAldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up studyHistopathology201158460861621371077
   PubMed Web of Science ®Google Scholar
• TsangJYHuangYHLuoMHCancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancerBreast Cancer Res Treat2012136240741723053657
   PubMed Web of Science ®Google Scholar
• YouQGuoHXuDDistinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancerDrug Des Devel Ther2015950875097
   PubMed Web of Science ®Google Scholar
• CondelloSMorganCANagdasSbeta-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroidsOncogene201534182297230824954508
   PubMed Web of Science ®Google Scholar